Scilex Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 2012-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.scilexpharma.com
Clinical Trials
13
Active:0
Completed:13
Trial Phases
3 Phases
Phase 1:11
Phase 2:1
Phase 3:1
Drug Approvals
1
FDA:1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (13 trials with phase data)• Click on a phase to view related trials
Phase 1
11 (84.6%)Phase 2
1 (7.7%)Phase 3
1 (7.7%)Clinical Adhesion Study Between ZTlido 1.8% and Three Over-the-counter External Analgesic Lidocaine-containing Patches
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: IcyHot (Lidocaine 4% + Menthol 1% Patch)
- First Posted Date
- 2021-11-03
- Last Posted Date
- 2021-11-03
- Lead Sponsor
- Scilex Pharmaceuticals, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT05106400
- Locations
- 🇺🇸
AXIS Clinicals, Dilworth, Minnesota, United States
Safety and Efficacy of SP-103 in Subjects With Moderate to Severe Acute Lower Back Pain
Phase 2
Completed
- Conditions
- Moderate to Severe Acute Lower Back Pain
- Interventions
- Drug: Placebo
- First Posted Date
- 2021-10-27
- Last Posted Date
- 2024-05-24
- Lead Sponsor
- Scilex Pharmaceuticals, Inc.
- Target Recruit Count
- 75
- Registration Number
- NCT05096494
- Locations
- 🇺🇸
Arizona Research Center, Phoenix, Arizona, United States
🇺🇸Costal Clinical Research Specialists, Jacksonville, Florida, United States
🇺🇸Horizon Clinical Research, Newnan, Georgia, United States
Pharmacokinetics of SP-104
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2021-08-12
- Last Posted Date
- 2022-05-03
- Lead Sponsor
- Scilex Pharmaceuticals, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT05002946
- Locations
- 🇳🇿
Christchurch Clinical Studies Trust (NZCR), Christchurch, New Zealand
Study to Evaluate the Safety of SP-104
Phase 1
Completed
- Conditions
- Healthy Volunteers
- Interventions
- First Posted Date
- 2021-07-12
- Last Posted Date
- 2022-01-31
- Lead Sponsor
- Scilex Pharmaceuticals, Inc.
- Target Recruit Count
- 52
- Registration Number
- NCT04958876
- Locations
- 🇳🇿
Auckland Clinical Studies (NZCR), Auckland, New Zealand
🇳🇿Christchurch Clinical Studies Trust (NZCR), Christchurch, New Zealand
Pharmacokinetic Study of SP-103 in Healthy Adult Human Subjects
- First Posted Date
- 2021-03-29
- Last Posted Date
- 2021-03-29
- Lead Sponsor
- Scilex Pharmaceuticals, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT04819581
- Locations
- 🇺🇸
AXIS Clinicals, Dilworth, Minnesota, United States
- Prev
- 1
- 2
- 3
- Next
News
No news found